narrows labs bpc 157 Dosage: A Doctor's Evidence-Based Guide BPC-157 - Clearlake Labs

AOD9604 (Advanced Obesity Drug) was developed by Professor Frank Ng at Monash University in Australia in the 1990s, with the intent of finding an anti-obesity drug that had the fat-burning effects of human growth hormone

While promising in research for fat metabolism and potentially cartilage repair, large trials showed good efficacy with AOD9604 for obesity, but it remains a research tool for studying fat burning and metabolic pathways, often used off-label in wellness settings alongside diet and exercise with promising affects for cartilage repair

If given IV, it must be injected slowly (often over at least 5 minutes or diluted in a larger volume bag and infused)

Performance Support By supporting recovery and tissue health, BPC-157 may help you maintain your performance in physical activities you love